4 Hemophilia Clinical Trials in Iowa City, IA (2026)

Q: How do I join a clinical trial in Iowa City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you.

Recruiting Hemophilia Studies in Iowa City

NCT07416604Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of NXT007 prophylaxis compared with emicizumab prophylaxis in people age 12 years and older with s...

Iowa City, IAPHASE3360 participantsHoffmann-La Roche

View Study Details

NCT05145127Recruiting

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in participants who did not require "Early Terminat...

Iowa City, IAPHASE3245 participantsPfizer

View Study Details

NCT07416526Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of NXT007 prophylaxis compared with Factor VIII (FVIII) prophylaxis in participants with severe or ...

Iowa City, IAPHASE3138 participantsHoffmann-La Roche

View Study Details

NCT05987449Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

WP44714 is a Phase I/II, open-label, non-randomized, global, multicenter trial consisting of two parts: * Part 1 is a multiple-ascending dose (MAD) study in adult and adolescent male participants wit...

Iowa City, IAPHASE160 participantsHoffmann-La Roche

View Study Details

About Hemophilia Clinical Trials in Iowa City

Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.

There are currently 4 hemophilia clinical trials recruiting participants in Iowa City, IA. These studies are seeking a combined 803 participants. Research is being sponsored by Hoffmann-La Roche, Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hemophilia Clinical Trials in Iowa City — FAQ

Are there hemophilia clinical trials in Iowa City?

Yes, there are 4 hemophilia clinical trials currently recruiting in Iowa City, IA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Iowa City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.

Are clinical trials in Iowa City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.

What hemophilia treatments are being tested?

The 4 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.

Data updated October 15, 2026 from ClinicalTrials.gov